A regular weekday of meals and food tracking from a creator on a GLP-1, built around what she had in the kitchen. A thin, familiar format.
Recap by typeshit. Video by SemaglutideandSanityđź’• on TikTok.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Full phase 3 data from EASD and The Lancet: 1,152 adults, three doses over 80 weeks, A1C down about 1.5 points, with diarrhea and nausea the top side effects.
Holly Lofton and Jennifer Manne-Goehler say safety looks similar to other GLP-1s so far, and Lofton reports gray market patients who saw no weight loss at all.
Loading…